Ovarian Cancer | Tumor

Zejula May Improve Survival in Certain Ovarian Cancer Subgroups

June 5th 2021, 5:00pm

Article

Progression-free survival improved with Zejula compared with placebo in patients with BRCA-mutated ovarian cancer with no new safety signals.

CURE’s Top Stories: May 2021

June 1st 2021, 6:00pm

Article

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2021.

Adding Tecentriq to Chemotherapy-Avastin Regimen Does Not Improve Efficacy in Ovarian Cancer

May 27th 2021, 6:00pm

Article

Evidence from a phase 3 trial does not support the addition of Tecentriq to a specific chemotherapy regimen with Avastin for patients with newly diagnosed stage 3 or 4 ovarian cancer.

Lynparza Maintenance Therapy Improves Survival Without Disease Progression in Subset of Patients With Ovarian Cancer

May 25th 2021, 9:00pm

Article

This maintenance therapy approach approved progression-free survival without a major impact on quality of life in patients with newly diagnosed ovarian cancer with a BRCA mutation who recently responded to chemotherapy.

Carboplatin Alone May Negatively Impact Survival in Patients With Ovarian Cancer

May 25th 2021, 1:00pm

Article

Vulnerable older patients with advanced ovarian cancer do not respond well to carboplatin treatment alone compared to a combination with paclitaxel.

A Family’s Journey with Ovarian Cancer, Genetic Testing and the BRCA1 Mutation

May 13th 2021, 3:00pm

Podcast

In this episode of the “CURE® Talks Cancer” podcast, Maria Ciesla, an ovarian cancer survivor, and her daughter Alex Cornwell discuss Ciesla’s cancer journey and how it led them to do genetic testing that revealed they were both carriers of the BRCA1 mutation.

CURE Honors World Ovarian Cancer Day

May 8th 2021, 3:00pm

Article

Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.

When Oncologists Retire, Their Patients Must Learn to Embrace Change

May 6th 2021, 4:00pm

Article

“We’re all blessed that there are so many dedicated, caring health care professionals willing to step in and fill the void when members of the team move or retire,” writes a patient with cancer. “We can never forget how tough a gig it is or say thank you enough.”

Making Strides in Ovarian Cancer

May 2nd 2021, 3:00pm

Article

Clinical trials are often the key to advancements in treating ovarian cancer. As part of its “Speaking Out” video series, CURE® spoke with Dr. Debra Richardson about what patients should know about joining a trial.

Cancer Survivors and Patients Share Their Experience With Seeking Second Opinions on Their Diagnosis and Treatment

April 19th 2021, 6:00pm

Article

On social media, CURE® recently asked its readers to share if they sought a second opinion when discussing their cancer diagnosis and treatment. Here’s what some of them said.